Schweiz - Deutsch - OFAG-BLW (Bundesamt für Landwirtschaft)

sfp europe sa - ethephon - 9500536 - frankreich - phytoregulator ;

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

medtronic biopharma sàrl - diboterminum alfa - pulver 12 mg, lösungsmittel und matrix für matrix zur implantation - praeparatio cryodesiccata: diboterminum alfa 12 mg, glycinum, natrii chloridum, saccharum, polysorbatum 80, acidum glutamicum, pro vitro. solvens: aqua ad iniectabile 10 ml pro vitro. solutio reconstituta: diboterminum alfa 1.5 mg/ml, natrium max. 0.05 mg/ml. tela cum: collagenum nativum. - osteosynthese: behandlung von frakturen der tibia bei erwachsenen, behandlung von discopathies-degenerativer erkrankungen bei erwachsenen - biotechnologika

Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

medtronic biopharma sàrl - diboterminum alfa - 4 mg pulver und lösungsmittel und matrix für matrix zur implantation - praeparatio cryodesiccata: diboterminum alfa 4 mg, glycinum, natrii chloridum, saccharum, polysorbatum 80, acidum glutamicum, pro vitro. solvens: aqua ad iniectabile 10 ml pro vitro. solutio reconstituta: diboterminum alfa 1.5 mg/ml, natrium max. 0.05 mg/ml. tela cum: collagenum nativum. - osteosynthese: behandlung von frakturen der tibia bei erwachsenen, behandlung von discopathies-degenerativer erkrankungen bei erwachsenen - biotechnologika

Europäische Union - Deutsch - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - impfstoffe - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. der einsatz dieses impfstoffs sollte in übereinstimmung mit den offiziellen empfehlungen.

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

bayer austria ges.m.b.h. - iopromid - iopromid

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

bayer austria ges.m.b.h. - iopromid - iopromid

Österreich - Deutsch - AGES (Agentur für Gesundheit und Ernährungssicherheit)

bayer austria gmbh - iopromid - iopromid

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ge healthcare buchler gmbh & co.kg (3022870) - iohexol - injektionslösung - teil 1 - injektionslösung; iohexol (22310) 518 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ge healthcare buchler gmbh & co.kg (3022870) - iohexol - injektionslösung oder lösung zum einnehmen - teil 1 - injektionslösung oder lösung zum einnehmen; iohexol (22310) 755 milligramm

Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

agfa healthcare imaging agents gmbh (8105193) - iohexol - injektions-/infusionslösung - teil 1 - injektions-/infusionslösung; iohexol (22310) 518 milligramm